ABVC BioPharma to Spin Off BioKey Subsidiary via Dividend Distribution to Shareholders
ABVC BioPharma spins off BioKey via dividend distribution to shareholders. Learn about the spin-off, shareholder benefits, and BioKey's role as a CRO/CDMO in nutraceuticals
2026/06/23